

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 9.25234937 |
| 2 | cytidine catabolic process (GO:0006216) | 9.25234937 |
| 3 | cytidine deamination (GO:0009972) | 9.25234937 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.16236188 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.01443330 |
| 6 | DNA deamination (GO:0045006) | 7.63814576 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.03307459 |
| 8 | T cell migration (GO:0072678) | 5.70523257 |
| 9 | positive T cell selection (GO:0043368) | 5.65673390 |
| 10 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.54495635 |
| 11 | actin nucleation (GO:0045010) | 5.49940343 |
| 12 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.44661112 |
| 13 | cytolysis (GO:0019835) | 5.38032645 |
| 14 | eosinophil chemotaxis (GO:0048245) | 5.33339882 |
| 15 | positive thymic T cell selection (GO:0045059) | 5.32334877 |
| 16 | negative regulation by host of viral transcription (GO:0043922) | 4.99571965 |
| 17 | regulation of activation of Janus kinase activity (GO:0010533) | 4.92018287 |
| 18 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.89467785 |
| 19 | negative regulation of T cell apoptotic process (GO:0070233) | 4.87888589 |
| 20 | eosinophil migration (GO:0072677) | 4.84404566 |
| 21 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.70692239 |
| 22 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.70692239 |
| 23 | sequestering of actin monomers (GO:0042989) | 4.60504355 |
| 24 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.56646225 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.52576167 |
| 26 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.43583288 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.40256248 |
| 28 | regulation of chronic inflammatory response (GO:0002676) | 4.39100535 |
| 29 | negative T cell selection (GO:0043383) | 4.18520433 |
| 30 | cellular response to interleukin-15 (GO:0071350) | 4.16076970 |
| 31 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.14590656 |
| 32 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.08254336 |
| 33 | positive regulation of cell killing (GO:0031343) | 4.03984406 |
| 34 | negative regulation of viral genome replication (GO:0045071) | 3.97293635 |
| 35 | regulation of regulatory T cell differentiation (GO:0045589) | 3.94218659 |
| 36 | macrophage chemotaxis (GO:0048246) | 3.88816606 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.87821914 |
| 38 | thymic T cell selection (GO:0045061) | 3.87460265 |
| 39 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.85838771 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.80266622 |
| 41 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.79628399 |
| 42 | positive regulation of tolerance induction (GO:0002645) | 3.75706682 |
| 43 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.75079000 |
| 44 | regulation of cell killing (GO:0031341) | 3.71767009 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 3.65246577 |
| 46 | T cell receptor signaling pathway (GO:0050852) | 3.62293533 |
| 47 | T cell selection (GO:0045058) | 3.60914686 |
| 48 | negative regulation of stress fiber assembly (GO:0051497) | 3.59249472 |
| 49 | regulation of calcium-mediated signaling (GO:0050848) | 3.57382952 |
| 50 | lymphocyte costimulation (GO:0031294) | 3.55786296 |
| 51 | iron-sulfur cluster assembly (GO:0016226) | 3.52100232 |
| 52 | metallo-sulfur cluster assembly (GO:0031163) | 3.52100232 |
| 53 | T cell costimulation (GO:0031295) | 3.51302364 |
| 54 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.46949409 |
| 55 | regulation of T cell chemotaxis (GO:0010819) | 3.44443396 |
| 56 | positive regulation of T cell chemotaxis (GO:0010820) | 3.44443396 |
| 57 | regulation of interleukin-8 secretion (GO:2000482) | 3.35928564 |
| 58 | positive regulation of T cell apoptotic process (GO:0070234) | 3.33914029 |
| 59 | regulation of T cell apoptotic process (GO:0070232) | 3.33561325 |
| 60 | lymphocyte chemotaxis (GO:0048247) | 3.32893343 |
| 61 | ATP synthesis coupled proton transport (GO:0015986) | 3.31199144 |
| 62 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.31199144 |
| 63 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.30301115 |
| 64 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.28621778 |
| 65 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.28158701 |
| 66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.27739742 |
| 67 | positive regulation of lymphocyte migration (GO:2000403) | 3.21996438 |
| 68 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.21933431 |
| 69 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20710584 |
| 70 | response to interleukin-15 (GO:0070672) | 3.19321389 |
| 71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.18665017 |
| 72 | lymphocyte migration (GO:0072676) | 3.17703977 |
| 73 | respiratory electron transport chain (GO:0022904) | 3.15773712 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 3.12431201 |
| 75 | electron transport chain (GO:0022900) | 3.10859578 |
| 76 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.10309910 |
| 77 | respiratory burst (GO:0045730) | 3.09481877 |
| 78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.08913362 |
| 79 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.08122570 |
| 80 | monocyte chemotaxis (GO:0002548) | 3.07092502 |
| 81 | negative regulation of viral transcription (GO:0032897) | 3.07083311 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.06131719 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05841646 |
| 84 | cellular defense response (GO:0006968) | 3.05412214 |
| 85 | positive regulation of interleukin-4 production (GO:0032753) | 3.03383123 |
| 86 | negative regulation of oxidoreductase activity (GO:0051354) | 3.02970380 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00978235 |
| 88 | regulation of tolerance induction (GO:0002643) | 2.99982935 |
| 89 | positive regulation of translational initiation (GO:0045948) | 2.98325959 |
| 90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92882720 |
| 91 | response to interferon-beta (GO:0035456) | 2.91464860 |
| 92 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.91451918 |
| 93 | negative thymic T cell selection (GO:0045060) | 2.86607261 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.84882956 |
| 95 | positive regulation of defense response to virus by host (GO:0002230) | 2.84708494 |
| 96 | T cell mediated immunity (GO:0002456) | 2.83160100 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.82890212 |
| 98 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.82650603 |
| 99 | regulation of viral genome replication (GO:0045069) | 2.82538222 |
| 100 | protein neddylation (GO:0045116) | 2.82203678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.06376611 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.74271589 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.26708834 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.85160054 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41031546 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.17603667 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.02041176 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.83530903 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.79787166 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 2.55804981 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.53988127 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.43717019 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30879003 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.25168105 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.17425984 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14001062 |
| 17 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.98305905 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.97366093 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90464463 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89562233 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82070213 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.81188725 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 1.75093579 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.73375501 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70344561 |
| 26 | GATA3_26560356_Chip-Seq_TH2_Human | 1.70161516 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69774454 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.65999767 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.63131935 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62642493 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.61666911 |
| 32 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.59909162 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.54400638 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52887769 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52380435 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43628383 |
| 37 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.36994668 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.36346203 |
| 39 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.34351584 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30638858 |
| 41 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.29921741 |
| 42 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.29616209 |
| 43 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27702135 |
| 44 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.26460440 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.26225861 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.21857787 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21773254 |
| 48 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21519952 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19759125 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17751548 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17318855 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16283775 |
| 53 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11756787 |
| 54 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10320100 |
| 55 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10320100 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09349035 |
| 57 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07504498 |
| 58 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07241387 |
| 59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05629839 |
| 60 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.05453380 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04514052 |
| 62 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02797211 |
| 63 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02363927 |
| 64 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01721837 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99973684 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.99700586 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99558624 |
| 68 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99274426 |
| 69 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98108675 |
| 70 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97274314 |
| 71 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97140360 |
| 72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96947165 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96164292 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95676234 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94437991 |
| 76 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.94202631 |
| 77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.93902383 |
| 78 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93708512 |
| 79 | P300_27268052_Chip-Seq_Bcells_Human | 0.92969414 |
| 80 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.90956005 |
| 81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89843542 |
| 82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.89316589 |
| 83 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89279822 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 0.89268410 |
| 85 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.89263948 |
| 86 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88290261 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88290261 |
| 88 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.87881711 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87579635 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.87226416 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87055030 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.86454816 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85205731 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.84816333 |
| 95 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.84583423 |
| 96 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84069091 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83749167 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83384603 |
| 99 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83303975 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82567741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 7.16126153 |
| 2 | MP0009785_altered_susceptibility_to | 3.89568050 |
| 3 | MP0006082_CNS_inflammation | 3.18493647 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.08362369 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.94658951 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 2.87783307 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.70501975 |
| 8 | MP0003866_abnormal_defecation | 2.57713130 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.52533596 |
| 10 | MP0005025_abnormal_response_to | 2.46182770 |
| 11 | MP0001800_abnormal_humoral_immune | 2.23725188 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.21132692 |
| 13 | MP0001873_stomach_inflammation | 2.16544401 |
| 14 | MP0002723_abnormal_immune_serum | 2.14333543 |
| 15 | MP0003045_fibrosis | 2.13143237 |
| 16 | MP0001819_abnormal_immune_cell | 2.11674707 |
| 17 | MP0001790_abnormal_immune_system | 2.01226389 |
| 18 | MP0005387_immune_system_phenotype | 2.01226389 |
| 19 | MP0002006_tumorigenesis | 1.99142572 |
| 20 | MP0003878_abnormal_ear_physiology | 1.95619425 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 1.95619425 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.85425991 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 1.83009848 |
| 24 | MP0000685_abnormal_immune_system | 1.77347975 |
| 25 | MP0003448_altered_tumor_morphology | 1.71852053 |
| 26 | MP0002102_abnormal_ear_morphology | 1.69171399 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.64366326 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.63455487 |
| 29 | MP0000716_abnormal_immune_system | 1.61892435 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.58359575 |
| 31 | MP0002933_joint_inflammation | 1.55423770 |
| 32 | MP0002398_abnormal_bone_marrow | 1.49048711 |
| 33 | MP0001905_abnormal_dopamine_level | 1.48320688 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.44985472 |
| 35 | MP0004147_increased_porphyrin_level | 1.43524609 |
| 36 | MP0002405_respiratory_system_inflammati | 1.42868753 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.42063254 |
| 38 | MP0003646_muscle_fatigue | 1.40953824 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.39894359 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.34155627 |
| 41 | MP0003787_abnormal_imprinting | 1.33416683 |
| 42 | MP0002722_abnormal_immune_system | 1.29108385 |
| 43 | MP0005166_decreased_susceptibility_to | 1.28258946 |
| 44 | MP0002419_abnormal_innate_immunity | 1.27896851 |
| 45 | MP0008872_abnormal_physiological_respon | 1.26725903 |
| 46 | MP0001919_abnormal_reproductive_system | 1.26121311 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.24659321 |
| 48 | MP0002163_abnormal_gland_morphology | 1.23514764 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.20846829 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.20530060 |
| 51 | MP0002429_abnormal_blood_cell | 1.16231655 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.16148465 |
| 53 | MP0008469_abnormal_protein_level | 1.14626020 |
| 54 | MP0003436_decreased_susceptibility_to | 1.12991312 |
| 55 | MP0003880_abnormal_central_pattern | 1.11761275 |
| 56 | MP0002693_abnormal_pancreas_physiology | 1.11389521 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.08889447 |
| 58 | MP0001661_extended_life_span | 1.08276653 |
| 59 | MP0004885_abnormal_endolymph | 1.07774512 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.07289326 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.05226743 |
| 62 | MP0003011_delayed_dark_adaptation | 1.04927324 |
| 63 | MP0001764_abnormal_homeostasis | 1.03790787 |
| 64 | MP0001968_abnormal_touch/_nociception | 1.02462693 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 0.99879551 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 0.99878496 |
| 67 | MP0004947_skin_inflammation | 0.99198712 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 0.98593311 |
| 69 | MP0003786_premature_aging | 0.98221708 |
| 70 | MP0001188_hyperpigmentation | 0.97885713 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.97779322 |
| 72 | MP0009763_increased_sensitivity_to | 0.94726770 |
| 73 | MP0002736_abnormal_nociception_after | 0.91263192 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.88937584 |
| 75 | MP0005389_reproductive_system_phenotype | 0.87769552 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.87501672 |
| 77 | MP0009764_decreased_sensitivity_to | 0.87464576 |
| 78 | MP0004134_abnormal_chest_morphology | 0.87193007 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.86567206 |
| 80 | MP0000858_altered_metastatic_potential | 0.86463179 |
| 81 | MP0003137_abnormal_impulse_conducting | 0.83972146 |
| 82 | MP0003075_altered_response_to | 0.83111237 |
| 83 | MP0004742_abnormal_vestibular_system | 0.80436556 |
| 84 | MP0005253_abnormal_eye_physiology | 0.79394555 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.78379604 |
| 86 | MP0001542_abnormal_bone_strength | 0.75991102 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.75164388 |
| 88 | MP0001984_abnormal_olfaction | 0.73179085 |
| 89 | MP0009745_abnormal_behavioral_response | 0.72351064 |
| 90 | MP0008873_increased_physiological_sensi | 0.71039041 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.70844265 |
| 92 | MP0002168_other_aberrant_phenotype | 0.69929978 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.68152358 |
| 94 | MP0008789_abnormal_olfactory_epithelium | 0.67369505 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.66032381 |
| 96 | MP0001970_abnormal_pain_threshold | 0.63916990 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.63234794 |
| 98 | MP0002822_catalepsy | 0.60903136 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.60381199 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.60096435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.57541072 |
| 2 | Aplastic anemia (HP:0001915) | 6.24546769 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.89153823 |
| 4 | Hypoproteinemia (HP:0003075) | 4.79197975 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 4.71828543 |
| 6 | IgG deficiency (HP:0004315) | 4.61543703 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50324138 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.17814596 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 4.10195148 |
| 10 | Abnormality of T cells (HP:0002843) | 3.81526591 |
| 11 | Combined immunodeficiency (HP:0005387) | 3.74089281 |
| 12 | Thyroiditis (HP:0100646) | 3.73338574 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.71291074 |
| 14 | Increased IgM level (HP:0003496) | 3.68724659 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 3.55037189 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.49239920 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 3.34341239 |
| 18 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.25331175 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.23800887 |
| 20 | Chronic diarrhea (HP:0002028) | 3.10061477 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.03280538 |
| 22 | Recurrent bronchitis (HP:0002837) | 2.98598362 |
| 23 | Abnormality of macrophages (HP:0004311) | 2.92903564 |
| 24 | Abnormality of eosinophils (HP:0001879) | 2.91937876 |
| 25 | Increased CSF lactate (HP:0002490) | 2.91777884 |
| 26 | Congenital stationary night blindness (HP:0007642) | 2.88652144 |
| 27 | Hepatocellular necrosis (HP:0001404) | 2.87987119 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.84490360 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.84490360 |
| 30 | B lymphocytopenia (HP:0010976) | 2.82954839 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.82942544 |
| 32 | Hypoalbuminemia (HP:0003073) | 2.79334745 |
| 33 | Abnormal albumin level (HP:0012116) | 2.79334745 |
| 34 | Increased muscle lipid content (HP:0009058) | 2.75550834 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.75320960 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.69230048 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.68051989 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.68051989 |
| 39 | Lipid accumulation in hepatocytes (HP:0006561) | 2.68036808 |
| 40 | Encephalitis (HP:0002383) | 2.64991529 |
| 41 | Stomatitis (HP:0010280) | 2.64772347 |
| 42 | Attenuation of retinal blood vessels (HP:0007843) | 2.63723300 |
| 43 | Lymphopenia (HP:0001888) | 2.61580790 |
| 44 | Hypoplasia of the thymus (HP:0000778) | 2.58487995 |
| 45 | Bronchitis (HP:0012387) | 2.58007571 |
| 46 | Acute encephalopathy (HP:0006846) | 2.57661270 |
| 47 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.57652484 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.56268790 |
| 49 | Pancreatic cysts (HP:0001737) | 2.51057737 |
| 50 | Hepatic necrosis (HP:0002605) | 2.50690864 |
| 51 | Abnormality of the prostate (HP:0008775) | 2.45658716 |
| 52 | Decreased central vision (HP:0007663) | 2.43089900 |
| 53 | Exertional dyspnea (HP:0002875) | 2.42005551 |
| 54 | Severe visual impairment (HP:0001141) | 2.39825173 |
| 55 | Amyotrophic lateral sclerosis (HP:0007354) | 2.39739731 |
| 56 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.38692622 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35693206 |
| 58 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34995065 |
| 59 | Leukocytosis (HP:0001974) | 2.33055920 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.32165211 |
| 61 | Recurrent otitis media (HP:0000403) | 2.30455959 |
| 62 | Acute hepatic failure (HP:0006554) | 2.29442737 |
| 63 | Cerebral edema (HP:0002181) | 2.28872252 |
| 64 | Meningitis (HP:0001287) | 2.26681802 |
| 65 | Hemiplegia (HP:0002301) | 2.25794798 |
| 66 | Pancreatic fibrosis (HP:0100732) | 2.24295931 |
| 67 | Abolished electroretinogram (ERG) (HP:0000550) | 2.20972978 |
| 68 | Hyponatremia (HP:0002902) | 2.20584566 |
| 69 | Cerebral palsy (HP:0100021) | 2.13598183 |
| 70 | Pancytopenia (HP:0001876) | 2.13237757 |
| 71 | True hermaphroditism (HP:0010459) | 2.09561956 |
| 72 | Abnormality of renal resorption (HP:0011038) | 2.05012397 |
| 73 | Obstructive lung disease (HP:0006536) | 2.04511725 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04511725 |
| 75 | Lymphoma (HP:0002665) | 2.03582991 |
| 76 | Bronchiectasis (HP:0002110) | 2.03465228 |
| 77 | Increased serum lactate (HP:0002151) | 2.02867865 |
| 78 | Joint swelling (HP:0001386) | 2.01511450 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00631941 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.00319187 |
| 81 | Chronic bronchitis (HP:0004469) | 1.98966420 |
| 82 | Pendular nystagmus (HP:0012043) | 1.98210423 |
| 83 | Optic disc pallor (HP:0000543) | 1.97522302 |
| 84 | Abnormality of midbrain morphology (HP:0002418) | 1.95667210 |
| 85 | Molar tooth sign on MRI (HP:0002419) | 1.95667210 |
| 86 | Agammaglobulinemia (HP:0004432) | 1.95283604 |
| 87 | Eosinophilia (HP:0001880) | 1.95039104 |
| 88 | Glycosuria (HP:0003076) | 1.91125000 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 1.91125000 |
| 90 | Recurrent viral infections (HP:0004429) | 1.88217479 |
| 91 | Recurrent fungal infections (HP:0002841) | 1.88202769 |
| 92 | Constricted visual fields (HP:0001133) | 1.87059949 |
| 93 | Oral leukoplakia (HP:0002745) | 1.85173773 |
| 94 | Lactic acidosis (HP:0003128) | 1.84510644 |
| 95 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80427192 |
| 96 | Radial bowing (HP:0002986) | 1.80294139 |
| 97 | IgM deficiency (HP:0002850) | 1.78242789 |
| 98 | Alkalosis (HP:0001948) | 1.76463916 |
| 99 | Gangrene (HP:0100758) | 1.74154968 |
| 100 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.72146957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 7.10765718 |
| 2 | TESK2 | 5.57330482 |
| 3 | TXK | 4.82284309 |
| 4 | BCKDK | 3.63180823 |
| 5 | MAP4K1 | 2.91781013 |
| 6 | TESK1 | 2.77719853 |
| 7 | ZAK | 2.60443813 |
| 8 | ITK | 2.37265894 |
| 9 | VRK2 | 2.36907145 |
| 10 | TAOK3 | 2.32385286 |
| 11 | LIMK1 | 2.23739460 |
| 12 | ADRBK2 | 2.05721730 |
| 13 | BUB1 | 2.01141766 |
| 14 | TLK1 | 1.88958603 |
| 15 | MAP3K12 | 1.85687260 |
| 16 | VRK1 | 1.70065269 |
| 17 | GRK7 | 1.64513919 |
| 18 | TEC | 1.63070605 |
| 19 | MAP3K11 | 1.55828572 |
| 20 | MUSK | 1.37734296 |
| 21 | SYK | 1.37370464 |
| 22 | PRKCQ | 1.36600300 |
| 23 | BTK | 1.31818816 |
| 24 | FES | 1.28970009 |
| 25 | GRK1 | 1.28609490 |
| 26 | EIF2AK3 | 1.26544178 |
| 27 | PIK3CA | 1.25784313 |
| 28 | GRK6 | 1.19442901 |
| 29 | CSK | 1.18176770 |
| 30 | LCK | 1.17578109 |
| 31 | ZAP70 | 1.15671832 |
| 32 | TNK2 | 1.15046108 |
| 33 | MYLK | 1.02542026 |
| 34 | SCYL2 | 0.98018831 |
| 35 | FRK | 0.93487282 |
| 36 | LYN | 0.91831326 |
| 37 | CDK19 | 0.87855839 |
| 38 | TIE1 | 0.86925660 |
| 39 | INSRR | 0.80491107 |
| 40 | MAPKAPK3 | 0.76449225 |
| 41 | WNK4 | 0.75335572 |
| 42 | ROCK1 | 0.70856121 |
| 43 | DAPK1 | 0.69794039 |
| 44 | NUAK1 | 0.64761854 |
| 45 | CSNK1G3 | 0.63991389 |
| 46 | RPS6KA5 | 0.63815978 |
| 47 | MST4 | 0.61517466 |
| 48 | NME1 | 0.59731154 |
| 49 | TYRO3 | 0.59036051 |
| 50 | FYN | 0.58860678 |
| 51 | RPS6KA4 | 0.58026649 |
| 52 | TBK1 | 0.57675040 |
| 53 | WNK3 | 0.57481845 |
| 54 | OBSCN | 0.55812325 |
| 55 | MAP4K2 | 0.55764232 |
| 56 | JAK3 | 0.53010227 |
| 57 | PASK | 0.51482458 |
| 58 | PIM1 | 0.50891335 |
| 59 | AURKA | 0.49140416 |
| 60 | INSR | 0.48597831 |
| 61 | IKBKE | 0.48082253 |
| 62 | PIK3CG | 0.47073253 |
| 63 | IGF1R | 0.46841888 |
| 64 | KIT | 0.46704428 |
| 65 | PRKCA | 0.44867962 |
| 66 | PRKCH | 0.44644110 |
| 67 | CSF1R | 0.43886347 |
| 68 | PAK1 | 0.43643705 |
| 69 | CSNK1G2 | 0.42584721 |
| 70 | LRRK2 | 0.41880809 |
| 71 | BLK | 0.41071923 |
| 72 | ADRBK1 | 0.41034435 |
| 73 | GRK5 | 0.37794958 |
| 74 | CSNK1A1L | 0.37337182 |
| 75 | PRKACA | 0.36672888 |
| 76 | DAPK3 | 0.36004734 |
| 77 | MATK | 0.35704690 |
| 78 | TRIM28 | 0.34884226 |
| 79 | HCK | 0.34683048 |
| 80 | MAP3K5 | 0.34613244 |
| 81 | PINK1 | 0.34286353 |
| 82 | CSNK1G1 | 0.33948226 |
| 83 | MAPK13 | 0.31616892 |
| 84 | RIPK4 | 0.30024681 |
| 85 | CAMK2A | 0.29887996 |
| 86 | IKBKB | 0.29804718 |
| 87 | MAP2K7 | 0.29668979 |
| 88 | MAP2K6 | 0.29297379 |
| 89 | CLK1 | 0.28646986 |
| 90 | NTRK2 | 0.26650481 |
| 91 | LMTK2 | 0.26365908 |
| 92 | CSNK1A1 | 0.25876316 |
| 93 | MAPK15 | 0.25791027 |
| 94 | PIM2 | 0.24089039 |
| 95 | SRC | 0.23470138 |
| 96 | ERBB2 | 0.22659267 |
| 97 | CSNK2A1 | 0.21772756 |
| 98 | OXSR1 | 0.21511673 |
| 99 | PRKCB | 0.20483438 |
| 100 | ABL1 | 0.18704994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.42809418 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.15321710 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.39789558 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.23682425 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.00059308 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.95873302 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.88889403 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.75851675 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.73450098 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.61150359 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.56950262 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.47818080 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.10609373 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.95937092 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83654821 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.73148308 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70334685 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.67473353 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.62887931 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61239216 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.59708833 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.59164080 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.55286534 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.43457237 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.41810732 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.37253831 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36008284 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.32820215 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30250610 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16570329 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05655418 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.05268338 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03670846 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02509938 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99675185 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99503180 |
| 37 | Asthma_Homo sapiens_hsa05310 | 0.93493966 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 0.92686989 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88578118 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83985180 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81379833 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80798546 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78471110 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76358192 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75846932 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75721022 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72661554 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71854366 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64463566 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64344090 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63721768 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61272507 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58677683 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57734658 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57622809 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57562949 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56787696 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56649074 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53425353 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52823906 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46621001 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 0.45565859 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45145801 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.42726255 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 0.42680870 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41281534 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40791516 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39865651 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39742582 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.39574484 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37844599 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.36370793 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.33921268 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32482330 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32384764 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32082793 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29649268 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26850732 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26768283 |
| 80 | RNA degradation_Homo sapiens_hsa03018 | 0.24165958 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23798902 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23372742 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.23225861 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21220422 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.20201950 |
| 86 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20000225 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.19764432 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.19455939 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19352622 |
| 90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.19256803 |
| 91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.15953210 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.15634230 |
| 93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.15452359 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.14884593 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13625839 |
| 96 | Homologous recombination_Homo sapiens_hsa03440 | 0.12870169 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12224764 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11668165 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11563942 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.11538564 |

